CHAPERONE

The CHAPERONE Study is open to enrollment! If you're interested in participating, please reach out to Yoofi Mensah: yoomensah@berkeley.edu

The CHAPERONE Study is testing an eye solution for slowing the progression of myopia in children. The solution is “microdosed atropine.” Atropine eye drops are currently approved by FDA to treat “lazy eye”; however, the medication is considered investigational in the CHAPERONE Study because is has not been approved specifically for slowing myopia progression.

In the CHAPERONE Study, a gentle mist is applied to each eye using a specialized dispenser. Each mist of the medication is about 1/4 the volume of an eye drop. Participants in the CHAPERONE Study will use the study medication in both eyes every night, about one hour before bedtime.

Participants in the CHAPERONE Study will receive all study-related care at no cost. This includes the study medication, as well as any visits to your study doctor’s office, or tests performed during those visits. If your child’s vision changes and new glasses are needed, an allowance will be provided for this expense.

Find out more here.